- Home
- NKTR vs BRBI Comparison
NKTR vs BRBI Comparison
Compare NKTR & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- BRBI
- Stock Information
- Founded
- NKTR 1990
- BRBI 2009
- Country
- NKTR United States
- BRBI Brazil
- Employees
- NKTR N/A
- BRBI N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- BRBI Finance: Consumer Services
- Sector
- NKTR Health Care
- BRBI Finance
- Exchange
- NKTR Nasdaq
- BRBI Nasdaq
- Market Cap
- NKTR 1.1B
- BRBI 1.2B
- IPO Year
- NKTR 1994
- BRBI N/A
- Fundamental
- Price
- NKTR $54.35
- BRBI $14.26
- Analyst Decision
- NKTR Strong Buy
- BRBI
- Analyst Count
- NKTR 5
- BRBI 0
- Target Price
- NKTR $89.00
- BRBI N/A
- AVG Volume (30 Days)
- NKTR 684.3K
- BRBI 26.6K
- Earning Date
- NKTR 11-06-2025
- BRBI 11-07-2025
- Dividend Yield
- NKTR N/A
- BRBI N/A
- EPS Growth
- NKTR N/A
- BRBI N/A
- EPS
- NKTR N/A
- BRBI 0.31
- Revenue
- NKTR $62,600,000.00
- BRBI N/A
- Revenue This Year
- NKTR N/A
- BRBI N/A
- Revenue Next Year
- NKTR N/A
- BRBI $29.31
- P/E Ratio
- NKTR N/A
- BRBI $11.69
- Revenue Growth
- NKTR N/A
- BRBI N/A
- 52 Week Low
- NKTR $6.48
- BRBI $12.15
- 52 Week High
- NKTR $66.92
- BRBI $67.01
- Technical
- Relative Strength Index (RSI)
- NKTR 44.64
- BRBI N/A
- Support Level
- NKTR $52.50
- BRBI N/A
- Resistance Level
- NKTR $61.81
- BRBI N/A
- Average True Range (ATR)
- NKTR 3.62
- BRBI 0.00
- MACD
- NKTR -0.51
- BRBI 0.00
- Stochastic Oscillator
- NKTR 19.45
- BRBI 0.00
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About BRBI BRBI BR Partners S.A. ADSs
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.